Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions

Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions

Introduction: Mirogabalin is a new drug from the gabapentinoid group first registered in Japan in 2019. It has found use in the treatment of peripheral neuropathic pain in diabetic neuropathy and postherpetic neuropathy. Purpose: In this article, we review studies on the efficacy and safety of mi...

Full description

Bibliographic Details
Main Authors: Weronika Gawel, Sylwia Zdun, Klaudia Walczak, Zuzanna Wesołowska, Przemysław Jędruszczak
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2023-01-01
Series:Quality in Sport
Subjects:
mirogabalin
neuropathy
pregabalin
Online Access:https://apcz.umk.pl/QS/article/view/41950

Similar Items

Similar Items